Coherus Biosciences | أصول متداولة



Current Assets تغيير تاريخ
AbbVie USD 25.58B 2.2B 2024-12
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
ALKERMES USD 1.48B 63.7M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Amarin USD 573.06M 22.34M 2025-03
Amgen USD 26.93B 2.1B 2025-03
Baxter International USD 8.85B 11M 2024-12
Biogen USD 7.63B 169.2M 2025-03
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Fujifilm JPY 1.58T 97.58B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Ironwood Pharmaceuticals USD 182.42M 3.81M 2024-12
Merck USD 35.5B 3.28B 2025-03
Myriad Genetics USD 287.2M 10.8M 2025-03
Pacira USD 759.96M 14.83M 2025-03
Perrigo USD 2.53B 51.1M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Xencor USD 521.27M 56.33M 2025-03
Zoetis USD 5.88B 109M 2025-03



Coherus Biosciences أصول متداولة - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Jul 2025.